Stock Price Forecast

March 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading PetVivo Holdings Inc chart...

About the Company

petvivo, inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. petvivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. petvivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. petvivo, inc, gel-del technologies, inc. and cosmetalife a corporation are all wholly-owned subsidiaries of petvivo holdings, inc.

Exchange

NASDAQ

Website

petvivo.com

$4M

Total Revenue

13

Employees

$16M

Market Capitalization

-1.41

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PETV News

PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV

23d ago, source: Business Insider

PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today that it ...

PetVivo Holdings, Inc. Approved to Dual List on Upstream

1mon ago, source: Yahoo Finance

MINNEAPOLIS, Feb. 27, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative ...

PetVivo Holdings Inc (PETV)

16d ago, source: Investing

On January 19, 2024, Robert J. Folkes informed the Board of Directors (the “Board”) of Petvivo Holdings, Inc. (PETV) that he will be resigning as Chief Financial Officer (“CFO”) of ...

PetVivo Holdings Inc. Wt

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer

17d ago, source: Nasdaq

MINNEAPOLIS, MN, US, March 11, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of ...

PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV

23d ago, source: Yahoo Finance

MINNEAPOLIS, MN, March 05, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative ...

PetVivo Holdings, Inc. Approved to Dual List on Upstream

18d ago, source: ADVFN

PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today its ...

PetVivo Holdings Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...